Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

NCT01563601 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: Obatoclax Mesylate, Carboplatine and Etoposide
DRUG: Carboplatin and Etoposide

Sponsor

Cephalon